Understanding Dexmedetomidine in Neonates After Open Heart Surgery
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine what happens to dexmedetomidine in the body after
it has been given to a newborn after heart surgery. We want to learn how long the drug stays
in the body, how the drug is metabolized by the body, and how well the medicine works at a
particular dose or amount.